Literature DB >> 16472374

Donepezil-induced nightmares in mild cognitive impairment.

Yurinosuke Kitabayashi, Hideki Ueda, Hideto Tsuchida, Tatsuhisa Yamashita, Jin Narumoto, Kenji Fukui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16472374     DOI： 10.1111/j.1440-1819.2006.01474.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN： 1323-1316            Impact factor:   5.188


× No keyword cloud information.
  3 in total

Review 1.  Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies.

Authors:  Elena Urrestarazu; Jorge Iriarte
Journal:  Nat Sci Sleep       Date:  2016-01-14

2.  A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study.

Authors:  Basil H Ridha; Sebastian Crutch; Dawn Cutler; Christopher Frost; William Knight; Suzie Barker; Norah Epie; Elizabeth K Warrington; Riitta Kukkastenvehmas; Jane Douglas; Martin N Rossor
Journal:  Alzheimers Res Ther       Date:  2018-05-01       Impact factor: 6.982

3.  Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer's Patients Treated with Donepezil: Case Series.

Authors:  Leszek Bidzan; Mariola Bidzan
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-06       Impact factor: 2.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.